Markey Cancer Center study shows potential for new radiopharmaceutical cancer treatment (IMAGE)

University of Kentucky

Markey Cancer Center study shows potential for new radiopharmaceutical cancer treatment

Caption

The study, led by UK Markey Cancer Center radiation oncologist Charles Kunos, M.D., and published in Frontiers in Oncology, validates that the radioactive drug 212Pb-DOTAM-GRPR1 may be useful in the treatment of persistent, recurrent, or metastatic cervical cancer.

Credit

Inside Creative House. iStock/Getty Images Plus.

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.